Prosecution Insights
Last updated: May 29, 2026

Caamtech Inc.

6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
5
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (83%)
0
Easy (0%)
1
Unknown (17%)

Rejection Statute Mix

BucketCases
§103 only2 (33%)
§102 only3 (50%)
No statute on record1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CORNET, JEAN P 2 42.0% +47.8%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.4% +41.3%
ANDERSON, JAMES D 1 55.1% +19.2%
SPAINE, ROBERT FRANKLIN 1
HOFFMAN, SUSAN COE 1 54.1% +25.6%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18544954 ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES CORNET, JEAN P 92d overdue
18858080 CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES ANDERSON, JAMES D 44d overdue
18865881 TRYPTAMINE DERIVATIVES ABDALHAMEED, MANAHIL MIRGHANI ALI 35d overdue
18257639 AMANITA MUSCARIA COMPOUNDS HOFFMAN, SUSAN COE 32d overdue
17495069 ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES CORNET, JEAN P 54d

Top Art Units

Art UnitApps
1628 2
1655 2
1622 1
1629 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18865881 TRYPTAMINE DERIVATIVES ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Non-Final OA 35d overdue Pending Nov 14, 2024
18858080 CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES ANDERSON, JAMES D 1629 §102 Non-Final OA 44d overdue Pending Oct 18, 2024
18544954 ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES CORNET, JEAN P 1628 §103 Non-Final OA 92d overdue Pending Dec 19, 2023
18352677 COMPOSITIONS CONTAINING KRATOM COMPOUNDS SPAINE, ROBERT FRANKLIN 1655 §102 Non-Final OA 441d overdue Pending Jul 14, 2023
18257639 AMANITA MUSCARIA COMPOUNDS HOFFMAN, SUSAN COE 1655 §102 Non-Final OA 32d overdue Pending Jun 15, 2023
17495069 ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES CORNET, JEAN P 1628 Other Non-Final OA 54d Pending Oct 06, 2021

Managing Caamtech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month